← Leaderboards
David M Sabatini
Whitehead Institute For Biomedical Res
$25,995,600
Attributed
$25,995,600
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2005–20$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$25,995,600 · 12
By mechanism
R01$19,264,429 · 5
R37$4,826,543 · 1
P50$690,247 · 2
R21$522,844 · 1
UH3$445,501 · 1
UH2$149,998 · 1
Top collaborators
No co-investigators on record.
Most similar at Whitehead Institute For Biomedical Res
Same institution · by research overlap
- Omer Yilmaz$16,106,393
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsResponsePathway InteractionsGrowthComplexProtein KinaseProteinsSirolimusSignal TransductionNutrientDiabetes MellitusIn VivoOrganismGrowth FactorMolecularStressMouse ModelHuman DiseaseInsightMammalsMediatingGenesMolecular Biology
Grant awards (71)
Novel Components of the mTORC1 and mTORC2 Pathways$487,500
R01 · FY2020 · AI · contact PI
Cell Growth Signaling in Cancer Development$463,125
R01 · FY2020 · CA · contact PI
Regulation of the mTOR Pathway by Nutrients$416,813
R01 · FY2020 · CA · contact PI
Exploiting mitochondrial heteroplasmy for cancer chemotherapy$390,000
R01 · FY2020 · CA · contact PI
Impact of aging on intestinal tumorigenesis$150,000
UH3 · FY2020 · CA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$487,500
R37 · FY2019 · AI · contact PI
Cell Growth Signaling in Cancer Development$449,231
R01 · FY2019 · CA · contact PI
Regulation of the mTOR Pathway by Nutrients$416,813
R01 · FY2019 · CA · contact PI
Exploiting mitochondrial heteroplasmy for cancer chemotherapy$378,300
R01 · FY2019 · CA · contact PI
HDM2 as a Therapeutic Target in RCC$265,751
P50 · FY2019 · CA · contact PI
Impact of aging on intestinal tumorigenesis$145,501
UH3 · FY2019 · CA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$487,500
R37 · FY2018 · AI · contact PI
Cell Growth Signaling in Cancer Development$463,125
R01 · FY2018 · CA · contact PI
Regulation of the mTOR Pathway by Nutrients$394,875
R01 · FY2018 · CA · contact PI
Exploiting mitochondrial heteroplasmy for cancer chemotherapy$390,000
R01 · FY2018 · CA · contact PI
Trageting mTOR Dependent Mechanism in Clear Cell Renal Carcinoma$212,463
P50 · FY2018 · CA · contact PI
Impact of aging on intestinal tumorigenesis$150,000
UH3 · FY2018 · CA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$487,500
R37 · FY2017 · AI · contact PI
Cell Growth Signaling in Cancer Development$402,576
R01 · FY2017 · CA · contact PI
Regulation of the mTOR Pathway by Nutrients$394,875
R01 · FY2017 · CA · contact PI
Exploiting mitochondrial heteroplasmy for cancer chemotherapy$390,000
R01 · FY2017 · CA · contact PI
Trageting mTOR Dependent Mechanism in Clear Cell Renal Carcinoma$212,033
P50 · FY2017 · CA · contact PI
Impact of aging on intestinal tumorigenesis$74,999
UH2 · FY2017 · CA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$487,500
R37 · FY2016 · AI · contact PI
Cell Growth Signaling in Cancer Development$402,576
R01 · FY2016 · CA · contact PI
Regulation of the mTOR Pathway by Nutrients$394,875
R01 · FY2016 · CA · contact PI
Impact of aging on intestinal tumorigenesis$74,999
UH2 · FY2016 · CA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$487,500
R37 · FY2015 · AI · contact PI
Cell Growth Signaling in Cancer Development$402,576
R01 · FY2015 · CA · contact PI
Regulation of the mTOR Pathway by Nutrients$394,875
R01 · FY2015 · CA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$482,625
R37 · FY2014 · AI · contact PI
Regulation of the mTOR Pathway by Nutrients$394,875
R01 · FY2014 · CA · contact PI
Cell Growth Signaling in Cancer Development$390,499
R01 · FY2014 · CA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$453,668
R37 · FY2013 · AI · contact PI
Cell Growth Signaling in Cancer Development$402,576
R01 · FY2013 · CA · contact PI
Regulation of the mTOR Pathway By Nutrients$355,974
R01 · FY2013 · CA · contact PI
Elucidating a mechanism of mTORC1 activation independent of amino acids signaling$230,344
R21 · FY2013 · AG · contact PI
Inhibitors of serine biosynthesis$47,288
R03 · FY2013 · DA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$482,625
R37 · FY2012 · AI · contact PI
Cell Growth Signaling in Cancer Development$402,576
R01 · FY2012 · CA · contact PI
Regulation of the mTOR Pathway By Nutrients$378,696
R01 · FY2012 · CA · contact PI
Elucidating a mechanism of mTORC1 activation independent of amino acids signaling$292,500
R21 · FY2012 · AG · contact PI
Inhibitors of serine biosynthesis$48,750
R03 · FY2012 · DA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$482,625
R37 · FY2011 · AI · contact PI
Cell Growth Signaling in Cancer Development$410,787
R01 · FY2011 · CA · contact PI
Regulation of the mTOR Pathway By Nutrients$378,696
R01 · FY2011 · CA · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$487,500
R37 · FY2010 · AI · contact PI
Cell Growth Signaling in Cancer Development$423,772
R01 · FY2010 · CA · contact PI
Regulation of the mTOR Pathway By Nutrients$390,408
R01 · FY2010 · CA · contact PI
Rapamycin-Insensitive Signaling by Rictor-mTOR$453,455
R01 · FY2009 · AI · contact PI
Cell Growth Signaling in Cancer Development$406,715
R01 · FY2009 · CA · contact PI
Regulation of the mTOR Pathway By Nutrients$390,408
R01 · FY2009 · CA · contact PI
Rapamycin-Insensitive Signaling by Rictor-mTOR$453,455
R01 · FY2008 · AI · contact PI
Cell Growth Signaling in Cancer Development$399,870
R01 · FY2008 · CA · contact PI
Regulation of the mTOR growth pathway by nutrients$369,317
R01 · FY2008 · CA · contact PI
Metabolism and Phosphatase Regulation of the TOR Pathway$323,567
R01 · FY2008 · GM · contact PI
Rapamycin-Insensitive Signaling by Rictor-mTOR$462,238
R01 · FY2007 · AI · contact PI
Regulation of the mTOR growth pathway by nutrients$369,317
R01 · FY2007 · CA · contact PI
Metabolism and Phosphatase Regulation of the TOR Pathway$323,567
R01 · FY2007 · GM · contact PI
Rapamycin-Insensitive Signaling by Rictor-mTOR$476,044
R01 · FY2006 · AI · contact PI
Regulation of the mTOR growth pathway by nutrients$380,347
R01 · FY2006 · CA · contact PI
Metabolism and Phosphatase Regulation of the TOR Pathway$316,997
R01 · FY2006 · GM · contact PI
Rapamycin-Insensitive Signaling by Rictor-mTOR$449,500
R01 · FY2005 · AI
Regulation of the mTOR growth pathway by nutrients$389,500
R01 · FY2005 · CA
Metabolism and Phosphatase Regulation of the TOR Pathway$314,650
R01 · FY2005 · GM
TRANSLATIONAL CONTROL BY RAPAMYCIN-SENSITIVE SIGNALING$427,500
R01 · FY2004 · AI
Regulation of the mTOR growth pathway by nutrients$371,050
R01 · FY2004 · CA
TRANSLATIONAL CONTROL BY RAPAMYCIN-SENSITIVE SIGNALING$412,188
R01 · FY2003 · AI
TRANSLATIONAL CONTROL BY RAPAMYCIN-SENSITIVE SIGNALING$271,250
R01 · FY2002 · AI
TRANSLATIONAL CONTROL BY RAPAMYCIN-SENSITIVE SIGNALING$271,250
R01 · FY2001 · AI
TRANSLATIONAL CONTROL BY RAPAMYCIN-SENSITIVE SIGNALING$271,250
R01 · FY2000 · AI